Etaphylline phenobarbital is indicated in chronic respiratory disease.

Etaphylline phenobarbital

Generic name :

Acefylline piperazine + phenobarbital.

Composition :

Each suppository contains:
Acefylline piperazine             500 mg
Phenobarbital                         100 mg
Excipient: SuppocireA

Pharmaceutical form :


Pharmacological actions :

Acepifylline (Acefylline piperazine) is a theophylline derivative which is used for its bronchodilator effects. Phenobarbital is used as a sedative in adults.

Indications :

Etaphylline phenobarbital suppository is indicated in chronic respiratory disease.

Dosage & administration :

One suppository or as prescribed by the physician.

Contraindications :

Hypersensitivity to any component of the product.

Side effects :

Some of the following side effects may occur in some-cases;
Nausea, vomiting, insomnia, headache and palpitation, general signs of central sedation (confusion, fatigue, vertigo

Drug interactions :

– Uses with other xanthines medication should be avoided.
– Simultaneous administration of CNS depressants medications and/or alcohol with Etaphylline phenobarbital suppository can potentiate their mutual effects.

Pregnancy and lactation :

Etaphylline phenobarbital suppository should not be administered during pregnancy and lactation.

Precautions & warnings :

– Etaphylline should be administered with caution to elderly patients and those suffering from cardiac and liver disease.

– Caution should be taken in patients with respiratory insufficiency due to the respiratory depressant effect of phenobarbital.

Therapeutic category :

bronchoditator and sedative

Legal category :


Storage :

Store at a temperature not exceeding 30°C, away from light.

Package :

Carton Box containing 5 or 10 suppositories in polyethylene strips

Produced by :

Memphis Co. For Pharm & Chemical ind – Cairo – Egypt

ايتافيللين فينوباربيتال لبوس لعلاج امراض الجهاز التنفسى المزمنة